MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study

  • Jan Laco
  • Helena Kovaříková
  • Marcela Chmelařová
  • Hana Vošmiková
  • Kateřina Sieglová
  • Ivana Baranová
  • Pavel Dundr
  • Kristýna Němejcová
  • Jaroslav Michálek
  • Jana Šatanková
  • Milan Vošmik
  • Aleš Ryška
Brief Report

Notes

Compliance with ethical standards

The experiments carried out in this study comply with the current laws of the Czech Republic. The study was approved by the Ethics Committee, University Hospital, Hradec Kralove, Czech Republic (no. 201602 I118P). As the research did not involve human participants and/or animals, neither informed consent nor statement of welfare of animals was needed.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

428_2018_2293_MOESM1_ESM.docx (17 kb)
ESM 1 (DOCX 17 kb)

References

  1. 1.
    Laco J, Sieglová K, Vošmiková H, Dundr P, Němejcová K, Michálek J, Čelakovský P, Chrobok V, Mottl R, Mottlová A, Tuček L, Slezák R, Chmelařová M, Sirák I, Vošmik M, Ryška A (2015) The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch 467(4):405–415.  https://doi.org/10.1007/s00428-015-1812-xCrossRefPubMedGoogle Scholar
  2. 2.
    Laco J, Vosmikova H, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Nekvindova J, Vosmik M, Cermakova E, Ryska A (2011) The role of high risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases. Virchows Arch 458(2):179–187.  https://doi.org/10.1007/s00428-010-1037-yCrossRefPubMedGoogle Scholar
  3. 3.
    Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, Hacova M, Ryska A (2012) Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16INK4a expression, and HPV status. Neoplasma 59(04):398–408.  https://doi.org/10.4149/neo_2012_052CrossRefPubMedGoogle Scholar
  4. 4.
    Laco J, Kovaříková H, Chmelařová M, Vošmiková H, Sieglová K, Bubancová I, Dundr P, Němejcová K, Michálek J, Čelakovský P, Mottl R, Sirák I, Vošmik M, Marek I, Geryk T, Mejzlík J, Šatanková J, Ryška A (2018) Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study. Neoplasma 65:101–111.  https://doi.org/10.4149/neo_2018_161122N581Google Scholar
  5. 5.
    Agaimy A, Koch M, Lell M, Semrau S, Dudek W, Wachter DL, Knöll A, Iro H, Haller F, Hartmann A (2014) SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol 38(9):1274–1281.  https://doi.org/10.1097/PAS.0000000000000236CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bishop JA, Antonescu CR, Westra WH (2014) SMARCB1 (INI-1)-deficient carcinoma of the sinonasal tract. Am J Surg Pathol 38(9):1282–1289.  https://doi.org/10.1097/PAS.0000000000000285CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Bell D, Hanna EY, Agaimy A, Weissferdt A (2015) Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch 467(6):649–656.  https://doi.org/10.1007/s00428-015-1853-1CrossRefPubMedGoogle Scholar
  8. 8.
    Allison DB, Bishop JA, Ali SZ (2016) Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: a potential diagnostic pitfall. Diagn Cytopathol 44(8):700–703.  https://doi.org/10.1002/dc.23503CrossRefPubMedGoogle Scholar
  9. 9.
    Wasserman JK, Dickson BC, Perez-Ordonez B, de Almeida JR, Irish JC, Weinreb I (2017) INI1 (SMARCB1)-deficient sinonasal carcinoma: a clinicopathologic report of 2 cases. Head Neck Pathol 11(2):256–261.  https://doi.org/10.1007/s12105-016-0752-3CrossRefPubMedGoogle Scholar
  10. 10.
    Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, Iro H, Lewis JS Jr, Märkl B, Mills SE, Riener MO, Robertson T, Sandison A, Semrau S, Simpson RH, Stelow E, Westra WH, Bishop JA (2017) SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol 41(4):458–471.  https://doi.org/10.1097/PAS.0000000000000797CrossRefPubMedGoogle Scholar
  11. 11.
    Laco J, Chmelařová M, Vošmiková H, Sieglová K, Bubancová I, Dundr P, Němejcová K, Michálek J, Čelakovský P, Mottl R, Sirák I, Vošmik M, Ryška A (2017) SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: a clinicopathological, immunohistochemical and molecular genetic study of a recently described entity. Pathol Res Pract 213(2):133–142.  https://doi.org/10.1016/j.prp.2016.10.012CrossRefPubMedGoogle Scholar
  12. 12.
    Chmelařová M, Sirák I, Mžik M, Sieglová K, Vošmiková H, Dundr P, Němejcová K, Michálek J, Vošmik M, Palička V, Laco J (2016) Importance of tumour suppressor gene methylation in sinonasal carcinomas. Folia Biol (Praha) 62(3):110–119Google Scholar
  13. 13.
    Kovarikova H, Bubancova I, Laco J, Sieglova K, Vosmikova H, Dundr P, Nemejcova K, Michalek J, Vosmik M, Palicka V, Chmelarova M (2017) Deregulation of selected microRNAs in sinonasal carcinoma: value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma. Head Neck 39(12):2528–2536.  https://doi.org/10.1002/hed.24930CrossRefPubMedGoogle Scholar
  14. 14.
    Jamali Z, Asl Aminabadi N, Attaran R, Pournagiazar F, Ghertasi Oskouei S, Ahmadpour F (2015) MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 51(4):321–331.  https://doi.org/10.1016/j.oraloncology.2015.01.008CrossRefPubMedGoogle Scholar
  15. 15.
    Sredni ST, Bonaldo Mde F, Costa FF, Huang CC, Hamm CA, Rajaram V, Tomita T, Goldman S, Bischof JM, Soares MB (2010) Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 26(3):279–283.  https://doi.org/10.1007/s00381-009-1028-yCrossRefPubMedGoogle Scholar
  16. 16.
    Grupenmacher AT, Halpern AL, Bonaldo Mde F, Huang CC, Hamm CA, de Andrade A, Tomita T, Sredni ST (2013) Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). Childs Nerv Syst 29(11):1977–1983.  https://doi.org/10.1007/s00381-013-2268-4CrossRefPubMedGoogle Scholar
  17. 17.
    Kohashi K, Yamamoto H, Kumagai R, Yamada Y, Hotokebuchi Y, Taguchi T, Iwamoto Y, Oda Y (2014) Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulated SMARCB1 mRNA expression. Mod Pathol 27(6):832–839.  https://doi.org/10.1038/modpathol.2013.213CrossRefPubMedGoogle Scholar
  18. 18.
    Sápi Z, Papp G, Szendröi PZ, Plótár V, Krausz T, Fletcher CD (2016) Epigenetic regulation of SMARCB1 by miR-2016, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas. Genes Chromosomes Cancer 55(10):786–802.  https://doi.org/10.1002/gcc.22379CrossRefPubMedGoogle Scholar
  19. 19.
    Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203–222.  https://doi.org/10.1038/nrd.2016.246CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Jan Laco
    • 1
  • Helena Kovaříková
    • 2
  • Marcela Chmelařová
    • 2
  • Hana Vošmiková
    • 1
  • Kateřina Sieglová
    • 1
  • Ivana Baranová
    • 2
  • Pavel Dundr
    • 3
  • Kristýna Němejcová
    • 3
  • Jaroslav Michálek
    • 4
  • Jana Šatanková
    • 5
  • Milan Vošmik
    • 6
  • Aleš Ryška
    • 1
  1. 1.The Fingerland Department of Pathology, Faculty of Medicine and University HospitalCharles UniversityHradec KraloveCzech Republic
  2. 2.Institute for Clinical Biochemistry and Diagnostics, Faculty of Medicine and University HospitalCharles UniversityHradec KraloveCzech Republic
  3. 3.Department of Pathology, First Faculty of Medicine and General University HospitalCharles UniversityPragueCzech Republic
  4. 4.Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry and University HospitalPalacky UniversityOlomoucCzech Republic
  5. 5.Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine and University HospitalCharles UniversityHradec KraloveCzech Republic
  6. 6.Department of Oncology and Radiotherapy, Faculty of Medicine and University HospitalCharles UniversityHradec KraloveCzech Republic

Personalised recommendations